Ensysce Biosciences Inc (ENSC) — Capital Reinvestment Ratio

Latest as of March 2020: 0.00x

Ensysce Biosciences Inc (ENSC) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($136.09 Million) in capital expenditures ($4.00). Check Ensysce Biosciences Inc (ENSC) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$136.09 Million
USD

Capital Expenditures

$4.00
USD

Data as of

Mar 2020
Most recent filing

Ensysce Biosciences Inc Capital Reinvestment Ratio (2019–2019)

This chart tracks Ensysce Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see ENSC cash flow conversion.

Annual Capital Reinvestment Ratio for Ensysce Biosciences Inc (2019–2019)

Year-by-year Capital Reinvestment Ratio for Ensysce Biosciences Inc from 2019 to 2019. See ENSC free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.00x $10.99 Million $4.00 —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow